Version 2.0 · Updated 2026-09-21 · Operations
Determine whether a supplier release affects approved GxP functions and what evidence or monitoring is required.
Adapt this template to your intended use, applicable requirements, and approved procedures.
When to use it
For scheduled and emergency releases to supplier-controlled multi-tenant services.
- Supplier release notes and deployment date
- Current configuration, integrations and open-record states
- Relevant supplier evidence and local risk/test records
Field instructions
- Release and date: Record the exact version/release and effective date from an authoritative source, including configuration identifiers needed to reproduce the assessment.
- Authoritative change information: Reference the supplier release notes or approved change request, including version, issue date and unresolved ambiguities.
- Affected GxP functions: Identify the function or requirement and its controlled reference. Explain the regulated process or record that depends on it.
- Configuration and interface exposure: List local settings, interfaces and existing record states touched by the release. Identify shared dependencies that need impact assessment.
- Potential failure and impact: Describe a credible incorrect, missing or delayed result and trace it to the affected process, record or decision. Distinguish severity from how often it could occur.
- Supplier evidence: Reference the exact evidence, version, date and assessed conditions. Explain the claim it supports, how it was reviewed and what remains unproven locally.
- Customer evidence needed: List the unanswered questions or missing evidence, the action owner and due date. Explain what cannot be concluded until they are resolved.
- Decision and rationale: Record the supported decision, restrictions, unresolved issues and rationale. Identify the accountable reviewer/approver and dated evidence under your procedure.
- Post-release monitoring: State what will be compared or monitored, against which baseline, by whom and how often. Define discrepancy thresholds and the response.
- Reassessment criteria and approval: Record the supported decision, restrictions, unresolved issues and rationale. Identify the accountable reviewer/approver and dated evidence under your procedure.
Review the authoritative release information.
Map changed components to enabled GxP functions and shared dependencies.
Assess risk, detectability, evidence, and open defects.
Choose no impact, targeted confirmation, regression, restriction, or escalation.
Completed fictional example
Fictional teaching example; this is not an executed or approved validation record.
Blank template
System / record ID: ____________________
Prepared by / date: ____________________
Required review / approval under local procedure: ____________________
Relevant regulations and guidance
These sources apply within their stated scope. The suggested worksheet fields, test designs and fictional decisions are practitioner recommendations, unless a source requirement is expressly identified. Completing a template does not establish compliance.
Regulatory guidance / GMP guideline · United States · February 2026
Scope: Medical-device manufacturers assuring software used in production or their quality management system.
Relevance: For medical-device production or QMS software, supports selecting assurance activities from intended use, risk and available evidence. It is nonbinding guidance and does not determine other sectors’ obligations.
Status: Final / published · Checked 2026-09-21
Publication identity, scope and status checked against the linked official source. This is not an independent audit of every retained guide statement.
Read source details and applicability →Regulatory guidance / GMP guideline · European Union · January 2011 revision
Scope: Computerised systems supporting activities in the applicable EU pharmaceutical GMP context.
Relevance: For computerised systems used in EU GMP activities, informs lifecycle, supplier and record controls. Confirm applicability to the actual activity; the example does not establish it.
Status: Final / published · Checked 2026-09-21
The Commission index confirms the January 2011 operative revision. The linked PDF could not be retrieved in this check; retained detailed section mappings need review against an authorized copy.
Read source details and applicability →